ECI
EIS
Stock
Stock
ISIN: TRAECILC91E0
Ticker: ECILC.E
TRAECILC91E0
ECILC.E
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 16.05.2025
$0.044
CHART BY
Frequently asked questions
What is EIS's market capitalization?
The market capitalization of EIS is $805.60M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is EIS's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for EIS is 30.26. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for EIS?
EIS's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.0369. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for EIS's stock?
Currently, 1 analysts cover EIS's stock, with a consensus target price of $0.085. Analyst ratings provide insights into the stock's expected performance.
What is EIS's revenue over the trailing twelve months?
Over the trailing twelve months, EIS reported a revenue of $214.45M.
Is EIS paying dividends?
Yes, EIS is paying dividends. The next payment is scheduled for 16.05.2025, with an expected amount of .
What is the EBITDA for EIS?
EIS's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $27.16M. EBITDA measures the company's overall financial performance.
What is the free cash flow of EIS?
EIS has a free cash flow of $67.92M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does EIS have, and what sector and industry does it belong to?
EIS employs approximately 1,088 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of EIS's shares?
The free float of EIS is 128.61M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $805.60M
- EPS (TTM)
- $0.0369
- Free Float
- 128.61M
- P/E ratio (TTM)
- 30.26
- Revenue (TTM)
- $214.45M
- EBITDA (TTM)
- $27.16M
- Free Cashflow (TTM)
- $67.92M
Pricing
- 52W span
- $0.999$1.961
Analyst Ratings
The price target is $0.085 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS is a holding company, which engages in the investment and management business. It operates through the Health and Real Estate Development segments. The Health segment is the production and sale of human health and veterinary medicine. The Real Estate Development segment is the sale and lease of properties and lands. The company was founded by Mehmet Nejat Eczacibasi, Melih Eczacibasi, Haluk Eczacibasi, Kemal Eczacibasi, and M. Sakir Eczacibas on October 24, 1951 and is headquartered in Istanbul, Turkey.
- Employees
- 1,088
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- TRAECILC91E0
- Primary Ticker
- ECILC.E
Fundamentals & EOD data from FactSet